Evidence map›Paper›PMID 37438348›Full record

ArticleNature communications2023

Structural and photophysical characterization of the small ultra-red fluorescent protein.

Atanu Maiti, Cosmo Z Buffalo, Saumya Saurabh, Felipe Montecinos-Franjola, Justin S Hachey, William J Conlon, Geraldine N Tran, Bakar Hassan, Kylie J Walters, Mikhail Drobizhev and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 2 countries.

Atanu MaitiCancer Innovation Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.ORCID 0000-0002-9080-1025
Cosmo Z BuffaloDepartment of Molecular and Cell Biology and California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, CA, 94720, USA.
Saumya SaurabhDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.
Felipe Montecinos-FranjolaDepartment of Chemistry, The George Washington University, Washington, DC, 20052, USA.ORCID 0000-0002-1823-103X
Justin S HacheyDepartment of Chemistry, The George Washington University, Washington, DC, 20052, USA.
William J ConlonDepartment of Chemistry, The George Washington University, Washington, DC, 20052, USA.
Geraldine N TranDepartment of Radiology, Boston University, Boston, MA, 02118, USA.
Bakar HassanProtein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Kylie J WaltersProtein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.ORCID 0000-0001-7590-2891
Mikhail DrobizhevDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, 59717, USA.ORCID 0000-0001-9072-1300
W E MoernerDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-2830-209X
Partho GhoshDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID 0000-0003-0254-5218
Hiroshi MatsuoCancer Innovation Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.ORCID 0000-0002-4559-6157
Roger Y TsienDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 92093, USA.
John Y LinTasmanian School of Medicine, University of Tasmania, Hobart, Tasmania, 7000, Australia.ORCID 0000-0002-1723-4597
Erik A RodriguezDepartment of Chemistry, The George Washington University, Washington, DC, 20052, USA. erik_rodriguez@gwu.edu.ORCID 0000-0001-9143-2535
George Washington University · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · USBoston University · USHoward Hughes Medical Institute · USMontana State University · USNew York University · USQB3 · USStanford University · USUniversity of California San Diego · USUniversity of Tasmania · AU

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
GENETIC MECHANISMS AND REGULATIONT32GM007240 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMPTON, RANDOLPH Y. · 1985 to 2019
$23.8M
New Probe and Methods for Correlated LM & EMR01GM086197 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, STEPHEN ROY, BOASSA, DANIELA · 2008 to 2020
$8.3M
Single-Molecule Imaging for Cell Biology and Super-Resolution MicroscopyR35GM118067 · NIGMS · STANFORD UNIVERSITY · PI MOERNER, WILLIAM E · 2016 to 2025
$6.2M
DYNAMICS OF SIGNAL TRANSDUCTION IN NEURONSR01NS027177 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, STEPHEN ROY, ELLISMAN, MARK H · 1989 to 2017
$5.8M
Myosin VI: a new ubiquitin receptorZIABC011627 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WALTERS, KYLIE · 2015 to 2025
$4.6M
Mechanisms of the M protein in group A Streptococcus virulenceR01AI096837 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO, NIZET, VICTOR · 2011 to 2015
$2.7M
Resource for Multiphoton Characterization of Genetically-Encoded ProbesU24NS109107 · NINDS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Mikhail Drobizhev · 2018 to 2026
$2.2M
Optogenetic mapping of synaptic activity and control of intracellular signalingU01NS090590 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KLEINFELD, DAVID, LIN, JOHN YU-LUEN · 2014 to 2016
$1.2M
Intramural NIH HHS ZIA BC011627NCI NIH HHS 75N91019D00024NIAID NIH HHS R01 AI096837NIGMS NIH HHS R01 GM086197NIGMS NIH HHS R35 GM118067NIGMS NIH HHS T32 GM007240NINDS NIH HHS R01 NS027177NINDS NIH HHS U01 NS090590NINDS NIH HHS U24 NS109107
6 · The paper itself

Abstract

The small Ultra-Red Fluorescent Protein (smURFP) represents a new class of fluorescent protein with exceptional photostability and brightness derived from allophycocyanin in a previous directed evolution. Here, we report the smURFP crystal structure to better understand properties and enable further engineering of improved variants. We compare this structure to the structures of allophycocyanin and smURFP mutants to identify the structural origins of the molecular brightness. We then use a structure-guided approach to develop monomeric smURFP variants that fluoresce with phycocyanobilin but not biliverdin. Furthermore, we measure smURFP photophysical properties necessary for advanced imaging modalities, such as those relevant for two-photon, fluorescence lifetime, and single-molecule imaging. We observe that smURFP has the largest two-photon cross-section measured for a fluorescent protein, and that it produces more photons than organic dyes. Altogether, this study expands our understanding of the smURFP, which will inform future engineering toward optimal FPs compatible with whole organism studies.

Indexed as

BiliverdineColoring AgentsEngineeringLuminescent ProteinsRed Fluorescent ProteinBiliverdineColoring AgentsLuminescent ProteinsRed Fluorescent Protein

Identifiers

PMID37438348
PMCPMC10338489
OpenAlexW4383988920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.